C-Booth Innovations Presents
An Elevated form of ECG Technology – founded by two emergency room physicians, inspired by the clinical need to improve the standard of patient care.
Better Data Faster





Engineered for
Cardiac Emergencies
The EXG™ system combines rapid deployment, accurate electrode placement, and allows for continuous diagnostic ECG monitoring across the patient episode of care in the most critical moments.
Expandable 12-Lead EKG
Expandable to 18-lead for Right-sided and Posterior visualization
AHA Compliant
Electrode placement follows American Heart Association standards
Motion Artifact Reduction
Improved methods for high-activity environments
Rapid Deployment
Single connection enables setup in under 60 seconds
Radiolucent Design
Continuous monitoring of rate and rhythm during CT-imaging procedures
Accuracy
Precise electrode placement ensures reliable diagnostic-quality ECG readings every time
Consistency
Standardized placement eliminates operator variability and ensures reproducible results
Post-ROSC ECG
Seamless transition to 12-lead monitoring after return of spontaneous circulation
3-Day Wear
Once skin is prepped, can be worn through diaphoresis and showering for extended monitoring
Single Cable
Universal compatibility - one cable fits any ECG monitor
EMS-to-ED Transition
Seamless handoff with no need to rewire or reposition with use of universal adapter.
Stress Test Lab
Can be worn for exercise treadmill stress testing with no modifications
Challenges With Current Standard-of-Care
User error, complexity, time-consuming processes, and burdensome workflows effect timely patient care and burden the health system.
Misplacement Can Hide Heart Attacks
Just 2 cm of electrode misplacement can obscure critical ST-segment changes and hide a heart attack (false negatives).
(Bond et al. 2012)
Decades Without Change
ECG toolsets have seen little innovation, remaining largely unchanged since the 1950s, calling for a modern approach to cardiac diagnostics.
Electrode Misapplication Rate
With a staggering electrode misapplication rate, the precision of ECG procedures is critically compromised, necessitating advancements in technology and training.
(Gregory et al. 2021)
Cath Lab False Alarms
Of unnecessary Cath Lab activations linked to ECG misinterpretation (false positives).
(Degheim et al. 2019)
Mortality Increase Per Minute
Each 1 minute delay increases mortality by 2%, making rapid ECG deployment critical.
(Zuworska-Wolak et al. 2019)
No ECG Within 10 Minutes
Of suspected STEMI patients did not receive ECG within 10 minutes.
(Stopyra et al. 2023)
Transmission Rate During MI
Only 28% transmission rates during acute MI, highlighting unreliable signal during transport.
(Bosson et al.)
Annual ECGs Performed
Annually, over 300 million ECGs are performed, showcasing the extensive reliance on this essential cardiac monitoring tool.
Comprehensive
Cardiac Monitoring
From simple rate and rhythm monitoring to continuous diagnostic monitoring - CBI has a complete portfolio for improving cardiac diagnostic outcomes.
EXG™ Wearable ECG Platform
Advanced 12-lead wearable ECG platform capable of expanding to 18-lead for improved STEMI detection.
- Continuous 12-lead monitoring
- Rapid deployment (<60 seconds)
- Single connection point
- Expandable to 18-lead
- +2 more features
- Improved STEMI detection
- AHA-compliant node placement
Easy Integration & Adopters
Seamless deployment of EXG™ across prehospital and acute care settings with comprehensive training.
- Universal monitor compatibility
- Fast, easy deployment
- Lower cost
- Improved performance
- +2 more features
- Follows existing workflows
- Improves AHA adherence
Cardiac Diagnostic Innovation
Precision monitoring platform for cardiac emergencies and critical care.
- AHA-compliant design standards
- FDA registered & ISO certified
- Motion artifact reduction
- Radiolucent design
- +2 more features
- Clinical studies
- Continuous innovation design
ECG Misplacement is a Pervasive, Costly Problem.
Macro-Market Fundamentals Driving Demand
Global population living with heart and circulatory diseases (British Heart Foundation 2023)
30% of Americans defined as clinically obese (CDC 2022)
Global deaths attributable to heart and circulatory diseases (British Heart Foundation 2023)
Annual heart attack wrongful death exposure (NEWMAN ET AL. 2022) (1.5% misdiagnosis rate, 40% malpractice win rate, $400k avg. indemnity payment)
Annual U.S. missed/delayed MI detection rate (Newman et al. 2022)
Ready to Transform Cardiac Care?
Schedule a demonstration of the EXG™ platform and discover how precision monitoring improves patient outcomes.

